参考文献/References:
[1] 郑振声,詹澄阳,伍时显,等.增强型体外反搏装置的设计及工作原理[J].中国生物医学工程学报,1984,3(3):133-139.
[2] 伍贵富,杜志民,冷秀玉.增强型体外反搏的作用机制与常见问题[J].新医学,2008,39(3):144-147.
[3] Chatzizisis YS, Coskun AU, Jonas M, et al.Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling:molecular,cellular,and vascular behavior[J].J Am Coll Cardiol,2007,49(25):2379-2393.
[4] 伍贵富,马虹,王奎健,等.体外反搏作用的新机制及其装置的新发展[J].中山大学学报(医学科学版),2006,27(6):606-609.
[5] Manchanda A, Soran O.Enhanced external counterpulsation and future directions:step beyond medical management for patients with angina and heart failure[J].J Am Coll Cardiol,2007,50(16):1523-1531.
[6] Stys T, Lawson WE, Hui JC, et al.Acute hemodynamic effects and angina improvement with enhanced external counterpulsation[J].Angiology,2001,52(10):653-658.
[7] 游云,张毅,廖福龙.血流剪应力、生物力药理学与疾病防治[J].微循环学杂志,2010,20(3):53-55.
[8] Deanfield JE, Halcox JP, Rabelink TJ.Endothelial function and dysfunction:testing and clinical relevance[J].Circulation,2007,115(10):1285-1295.
[9] Lerman A, Zeiher AM.Endothelial function:cardiac events[J].Circulation,2005,111(3):363-368.
[10] Tomczyk M, Nowak W, Jazwa A.Endothelium in physiology and pathogenesis of diseases[J].Postepy Biochem,2013,59(4):357-364.
[11] Ramos-Casals M.The ill endothelium:how atherosclerosis begins in lupus[J].Rheumatology(Oxford),2014,53(4):583-585.
[12] Beck DT, Martin JS, Casey DP, et al.Enhanced external counterpulsation improves endothelial function and exercise capacity in patients with ischaemic left ventricular dysfunction[J].Clin Exp Pharmacol Physiol,2014,41(9):628-636.
[13] Liu Y, Xiong Y, Liu D, et al.The effect of enhanced external counterpulsation on C-reactive protein and flow-mediated dilation in porcine model of hypercholesterolaemia[J].Clin Physiol Funct Imaging,2012,32(4):262-267.
[14] Gurovich AN, Braith RW.Enhanced external counterpulsation creates acute blood flow patterns responsible for improved flow-mediated dilation in humans[J].Hypertens Res,2013,36(4):297-305.
[15] Luo C, Liu D, Wu G, et al.Effect of enhanced external counterpulsation on coronary slow flow and its relation with endothelial function and inflammation:a mid-term follow-up study[J].Cardiology,2012,122(4):260-268.
[16] 刘荣,廖晓星,李欣,等.增强型体外反搏对心脏骤停犬血管内皮的影响[Z].中国广东广州:2012.
[17] Akhtar M, Wu GF, Du ZM, et al.Effect of external counterpulsation on plasma nitric oxide and endothelin-1 levels[J].Am J Cardiol,2006,98(1):28-30.
[18] Yang DY, Wu GF.Vasculoprotective properties of enhanced external counterpulsation for coronary artery disease: beyond the hemodynamics[J].Int J Cardiol,2013,166(1):38-43.
[19] Zhang Y, He X, Chen X, et al.Enhanced external counterpulsation inhibits intimal hyperplasia by modifying shear stress responsive gene expression in hypercholesterolemic pigs[J].Circulation,2007,116(5):526-534.
[20] Braith RW,Conti CR,Nichols WW,et al.Enhanced external counterpulsation improves peripheral artery flow-mediated dilation in patients with chronic angina:a randomized sham-controlled study[J].Circulation,2010,122(16):1612-1620.
[21] Xiong Y, Ren YF, Xu J, et al.Enhanced external counterpulsation inhibits endothelial apoptosis via modulation of BIRC2 and Apaf-1 genes in porcine hypercholesterolemia[J].Int J Cardiol,2014,171(2):161-168.
[22] Zhang Y, Yang X, Bian F, et al.TNF-alpha promotes early atherosclerosis by increasing transcytosis of LDL across endothelial cells:crosstalk between NF-kappaB and PPAR-gamma[J].J Mol Cell Cardiol,2014,72:85-94.
[23] Casey DP,Conti CR,Nichols WW,et al.Effect of enhanced external counterpulsation on inflammatory cytokines and adhesion molecules in patients with angina pectoris and angiographic coronary artery disease[J].Am J Cardiol,2008,101(3):300-302.
[24] Zhang Y, He X, Liu D, et al.Enhanced external counterpulsation attenuates atherosclerosis progression through modulation of proinflammatory signal pathway[J].Arterioscler Thromb Vasc Biol,2010,30(4):773-780.
[25] 蔡兴明,张爱霞,谢强,等.增强型体外反搏对冠心病患者炎症因子的影响[J].实用医学杂志,2012,28(10):1622-1625.
[26] Gan L, Miocic M, Doroudi R, et al.Distinct regulation of vascular endothelial growth factor in intact human conduit vessels exposed to laminar fluid shear stress and pressure[J].Biochem Biophys Res Commun,2000,272(2):490-496.
[27] Wu G, Du Z, Hu C, et al.Angiogenic effects of long-term enhanced external counterpulsation in a dog model of myocardial infarction[J].Am J Physiol Heart Circ Physiol,2006,290(1):H248-H254.
[28] Wu GF, Du ZM, Hu CH, et al.Microvessel angiogenesis:a possible cardioprotective mechanism of external counterpulsation for canine myocardial infarction[J].Chin Med J(Engl),2005,118(14):1182-1189.
[29] Luo JY, Wu GF, Xiong Y, et al.Enhanced external counterpulsation promotes growth cytokines-mediated myocardial angiogenesis in a porcine model of hypercholesterolemia[J].Chin Med J(Engl),2009,122(10):1188-1194.
[30] Jewell CW, Houck PD, Watson LE, et al.Enhanced external counterpulsation is a regenerative therapy[J].Front Biosci(Elite Ed),2010,2:111-121.
[31] Buschmann EE, Utz W, Pagonas N, et al.Improvement of fractional flow reserve and collateral flow by treatment with external counterpulsation(Art.Net.-2 Trial)[J].Eur J Clin Invest,2009,39(10):866-875.
[32] Shechter M, Matetzky S, Feinberg MS, et al.External counterpulsation therapy improves endothelial function in patients with refractory angina pectoris[J].J Am Coll Cardiol,2003,42(12):2090-2095.
[33] Nichols WW, Estrada JC, Braith RW, et al.Enhanced external counterpulsation treatment improves arterial wall properties and wave reflection characteristics in patients with refractory angina[J].J Am Coll Cardiol,2006,48(6):1208-1214.
[34] Braith RW, Casey DP, Beck DT.Enhanced external counterpulsation for ischemic heart disease: a look behind the curtain[J].Exerc Sport Sci Rev,2012,40(3):145-152.
相似文献/References:
[1]杜钧,佘强.冠心病抗炎治疗的临床研究进展[J].心血管病学进展,2016,(1):32.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.009]
DU Jun,SHE Qiang.Clinical Research Progress of Anti-inflammatory Therapy of Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2016,(2):32.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.009]
[2]努热曼古丽·阿布都克热木,马依彤.重度左心室收缩功能不全的冠心病患者血运重建治疗疗效及预后的评价[J].心血管病学进展,2016,(1):46.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.012]
NUREMANGULI·Abudukeremu,MA Yitong.Evaluation of Efficacy and Prognosis of Revascularization Therapy on Patients
with Coronary Heart Disease and Severe Left Ventricular Systolic Dysfunction[J].Advances in Cardiovascular Diseases,2016,(2):46.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.012]
[3]杨洋,综述,沈比先,等.心脏核磁共振评估缺血性心脏病的应用价值[J].心血管病学进展,2016,(2):204.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.028]
YANG Yang,SHEN Bixian.Value of Cardiac Magnetic Resonance Assessment of Ischemic Heart Disease[J].Advances in Cardiovascular Diseases,2016,(2):204.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.028]
[4]史敬,综述,马依彤,等.n-3多不饱和脂肪酸对心血管疾病的临床应用[J].心血管病学进展,2016,(3):278.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.016]
SHI Jing,MA Yitong.Effects of n-3 Polyunsaturated Fatty Acids on Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2016,(2):278.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.016]
[5]高柳,袁晋青.重复支架置入术治疗药物洗脱支架再狭窄的研究进展[J].心血管病学进展,2015,(5):555.[doi:10.3969/j.issn.1004-3934.2015.05.008]
GAO Liu,YUAN Jingqing.Progress in Treatment for Drug-eluting Stent Restenosis by
Re-implementation of Stents[J].Advances in Cardiovascular Diseases,2015,(2):555.[doi:10.3969/j.issn.1004-3934.2015.05.008]
[6]邓文政,邓平.MG53蛋白的研究进展[J].心血管病学进展,2015,(5):626.[doi:10.3969/j.issn.1004-3934.2015.05.027]
DENG Wenzheng,DENG Ping.Research Progress of MG53[J].Advances in Cardiovascular Diseases,2015,(2):626.[doi:10.3969/j.issn.1004-3934.2015.05.027]
[7]陈静,李兴德.冠心病患者服药依从性的研究进展[J].心血管病学进展,2015,(6):728.[doi:10.3969/j.issn.1004-3934.2015.06.018]
CHEN Jing,LI Xingde.Advances in Medication Adherence of Patients with Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2015,(2):728.[doi:10.3969/j.issn.1004-3934.2015.06.018]
[8]姚雯,毛露,孙硕,等.心源性外泌体作为冠心病标志物和新靶点展望[J].心血管病学进展,2019,(6):844.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.002]
YAO Wen,MAO Lu,SUN Shuo,et al.Exogenous Exosome as A New Marker and Target of Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2019,(2):844.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.002]
[9]郭彩艳 靳春荣.腺苷药物在心血管疾病诊治中的应用进展[J].心血管病学进展,2019,(7):1011.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.012]
GUO CaiyanJIN Chunrong.Progress in the Application of Adenosine Drugs in the Diagnosis and Treatment of Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2019,(2):1011.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.012]
[10]方砚 王效浣 郭朝霞.血流介导性血管扩张评价心血管病患者肱动脉内皮功能的研究进展[J].心血管病学进展,2019,(5):793.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.032]
FANG Yan,WANG Xiaohuan,GUO Zhaoxia.Flow- mediated Vasodilation Evaluation of Brachial Artery Endothelial Function in Patients with Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(2):793.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.032]